Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Anthony M. Manning

Director at Monte Rosa Therapeutics, Inc. (GLUE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $411K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 30SEC GLUEMonte Rosa Therapeutics, Inc. Sell 10,000 $23.11 $231K -57.9%
May 22SEC GLUEMonte Rosa Therapeutics, Inc. Sell 10,000 $18.01 $180K -45.9%